Podcasts about CMS

This week I talk about The 2022 Recession & How it May Affect Your Business [powerpoint]

43% aller Webseiten laufen auf dem Content-Managent-System WordPress. Damit kommt man um WordPress kaum herum, wenn man sich mit Internetseiten beschäftigt. Sehr häufig müssen sich Nicht-Webdesigner/-Entwickler mit WordPress beschäftigen und sich nebenbei mit der Firmenwebseite beschäftigen. In dem Webinar gibt Dir der WordPress-Experte Tim Ehling einen Einblick und eine Orientierung zu dem CMS. Denn WordPress ist nicht gleich WordPress. Die Informationsfülle im Internet ist riesig und der Einstieg in das CMS fällt nicht jedem leicht. Folgendes hast Du nach dem Webinar gelernt: wann WordPress für Dich das richtige ist was Du vor dem Start mit WordPress beachten solltest wie Du WordPress meistern kannst wo Du die richtigen Plugins, Themes oder Hilfe finden kannst Zielgruppe: Personen die sich mit WordPress noch nicht richtig beschäftigt haben Personen die einen Blick in die Möglichkeiten von WordPress werfen möchten Personen die sich um die Firmenwebseite kümmern sollen und keine Web-Designer sind Das OMT Webinar ist bald verfügbar Alle OMT-Webinare in Deinem Kalender

 It seems every week we hear of another new proposal out of Washington DC to ‘fix' drug pricing, and many of the companies that would be impacted by these proposals are in California, arguably, the globe's leading biotech hub, and where the sector was born. Joe Panetta is President & CEO of Biocom California, the association representing the life science industry in California. With offices in San Diego, Los Angeles, Sacramento, and the Bay Area, Biocom California advocates for more than 1,600 companies, service sector firms, universities, and research institutes working across the state in the biotechnology sector. Joe's been the head of Biocom California since 1999 and is universally regarded as one of the world's thought leaders in innovative biopharma.  In this podcast, Joe provides insightful comments about the birth of the biotechnology industry, the current business climate, and what continues to make California such an attractive and vibrant life science cluster, in spite of the turbulent equity markets and near double digit inflation.  He'll also discuss the ever-increasing challenges and storm waves being hurled at innovative biotech companies by Congress, including proposals to change the criteria of the accelerated approval pathway, CMS' ability to limit access to treatments by requesting more evidence, proposed pricing negotiations resurrected from Build Back Better, and the recent statements by Senator Elizabeth Warren (D-Mass) to use march-in rights to lower the price of therapies  See omnystudio.com/listener for privacy information.

Im CMS Umfeld hört man heutzutage viele neue Begriffe wie „decoupled“ und „headless“. Was bedeuten diese Begriffe, welche Technologien stehen dahinter und vor allen Dingen – was bringen headless CMS Systeme gegenüber herkommlichen CMS Systemen? Und reicht es allein ein headless CMS einzuführen? In diesem Podcast rede ich - auf Englisch - mit Knut Melvær, Head of Developer Relations bei Sanity.io (https://www.sanity.io). Früher war Knut Senior Technology Consultant bei Netlife, eine renommiertes norwegisches UX und Design Agency. Knut gibt einen Einblick in die Veränderungen im CMS Umfeld, welche Vorteile solche Änderungen mit sich bringen und, ob die Einführung eines headless CMS allein reicht. Darüber hinaus erklärt Knut was ein headless CMS aus technischer Sicht ist, wie eine Migration zu einem headless CMS stattfinden kann und welche betrieblichen Aspekte zu berücksichtigen sind. Wenn Ihr Themen habt, die Ihr gern in einem Podcast beleuchtet haben möchtet, sendet eine Email an podcast@takstsoft.com. Viel Spaß beim Reinhören und bis zum nächsten Mal! Euer Taktsoft Campus Podcast Team

Join Health Affairs Insider.Listen to Health Affairs' Chris Fleming interview Manatt Health's Cindy Mann on budget neutrality requirements for Medicaid 1115 demonstrations.This episode was recorded on June 23, 2022.Related Links: Rethinking The Budget Neutrality Requirement for Medicaid 1115 Demonstrations (Health Affairs Forefront)Currently, more than 70 percent of our content is freely available — and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

How do you teach your children to pray? What are some practical tips on instilling a prayer life into your child? Is there anything more important? http://www.patreon.com/thecatholicmanshow (Become a Patron! Over 40 interviews, a course with Karlo Broussard, a 10 part series on the domestic church, a course on fitness and virtue by Pat Flynn, and free thank you gifts for supporting the show!) https://selectinternationaltours.com/catholicmanshow/ () WE ARE GOING TO IRELAND WITH FR. SEAN DONOVAN AND THERE ARE STILL A FEW SPOTS LEFT! JOIN US – https://selectinternationaltours.com/catholicmanshow/ (MORE DETAILS HERE). About our drink: Rampur Double Cask Indian Single Malt Whisky India- Full-bodied aroma of tropical fruits, smooth malty tones, and oaky notes combining to produce an array of flavors. Matured in American bourbon barrels and European sherry casks. About our gear: A solar power bank About the Topic: How do you teach your children to pray? What are some practical tips on instilling a prayer life into your child? Is there anything more important as a father than to teach your children to have a relationship with Christ? How do you do it? This episode is sponsored by: https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS (CHRIST CENTERED CAPITAL) We point out what companies, organizations and charities are aligned with Christian Values, and which are not, so you can make morally informed decisions on what to do with your capital. https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS (Use promo code TCMS2022 for a 1 month free subscription. ) https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS () http://exodus90.com/tcms (What's your holy hour look like? ) There's a common thread among thousands of formerly sinful people we now call Saints. They had a relationship with God. Which then inspired them to ‘set the world on fire' as Catherine of Sienna put it. But, more specifically, it meant they put in the time. They sat with the Lord. Spoke with Him. Listened to Him. Daily. They unveiled their hearts and wounds and problems to Him. They offered him thanks and gratitude. They left their sufferings with Him on the altar. They begged for His help. My question to you: are you putting in the time? I'm not talking about time to just talk at Him or sit in church making a mental grocery list. I'm talking about time to build a consistent, honest relationship. Time to speak, and time to listen. Whether you want to pray a daily holy hour or hit up adoration once a week, I have a guide here from the makers of Exodus 90 specifically about praying a Holy Hour. Inside, you'll find a simple breakdown that shows you how to structure your time with the Lord. You can grab the mobile-friendly guide for free at http://exodus90.com/tcms (Exodus90.com/tcms) TIME CODES: If this is your first time listening to The Catholic Man Show, we do 3 things almost every episode:1.) Open, review, and enjoy a man beverage – Minutes 1-12.2.) Highlight a man gear – Minutes 12-24.3.) Have a manly conversation – Minutes 24-48If you haven't listened to The Catholic Man Show before, check out our previous episodes https://thecatholicmanshow.com/episodes/ (here). Subscribe to our https://www.youtube.com/channel/UC5MhmMZZhEnrapVYUIkFHLg?view_as=subscriber ( YouTube channel) to watch past episodes. Want to help The Catholic Man Show? By giving us a rating on https://itunes.apple.com/us/podcast/the-catholic-man-show/id1128843873?mt=2 (iTunes, it helps others find the show.) Want to say up with The Catholic Man Show? Sign up for our mailing list: http://www.thecatholicmanshow.com/manly (Click Here) Looking for a prayer to pray with your wife?...

In this episode of Syntax, Wes and Scott talk about their tips for better communication in email, Zoom calls, code reviews, or asking for help. Sentry - Sponsor If you want to know what's happening with your code, track errors and monitor performance with Sentry. Sentry's Application Monitoring platform helps developers see performance issues, fix errors faster, and optimize their code health. Cut your time on error resolution from hours to minutes. It works with any language and integrates with dozens of other services. Syntax listeners new to Sentry can get two months for free by visiting Sentry.io and using the coupon code TASTYTREAT during sign up. Sanity - Sponsor Sanity.io is a real-time headless CMS with a fully customizable Content Studio built in React. Get a Sanity powered site up and running in minutes at sanity.io/create. Get an awesome supercharged free developer plan on sanity.io/syntax. Auth0 - Sponsor Auth0 is the easiest way for developers to add authentication and secure their applications. They provides features like user management, multi-factor authentication, and you can even enable users to login with device biometrics with something like their fingerprint. Not to mention, Auth0 has SDKs for your favorite frameworks like React, Next.js, and Node/Express. Make sure to sign up for a free account and give Auth0 a try with the link below. https://a0.to/syntax Show Notes 00:10 Welcome 01:39 Furnace wiring fun Ecobee Tweet asking for communication tips 05:37 Email communication SavvyCal Calendly 15:07 Recognizing a big ask Simeon Griggs - How to ask for things 24:01 Sponsor: Sentry 25:52 Code review communication 30:39 Sponsor: Sanity 32:22 Sharing information with a video 35:42 In person or one on ones 39:36 Video calls Storyboard.fm 40:54 Realize it's ok to stop talking 42:27 Sponsor: Auth0 44:13 Tips from Twitter 53:08 ××× SIIIIICK ××× PIIIICKS ××× ××× SIIIIICK ××× PIIIICKS ××× Scott: Drachinifel Wes: Lepy LP-2020A Hi-Fi Stereo Audio Shameless Plugs Scott: LevelUp Tutorials on YouTube Wes: Wes Bos Tutorials Tweet us your tasty treats Scott's Instagram LevelUpTutorials Instagram Wes' Instagram Wes' Twitter Wes' Facebook Scott's Twitter Make sure to include @SyntaxFM in your tweets

In dieser Folge fachsimple ich zum ersten Mal öffentlich - und zwar mit meinem Tandem-Partner und Freund Jonas Tietgen. Wir gehen der Frage nach, ob sich WordPress ausnahmslos als CMS für Einzelunternehmerinnen und Einzelunternehmer eignet - oder ob es auch andere sinnvolle Alternativen gibt. Die im Podcast versprochenen "Goodies" sind: a) von Jonas Speziell für Dich als Hörerin oder Hörer des Marketing-Zauber-Podcasts kannst Du hier kostenlos und ohne Registrierung das frisch überarbeitete ToolKit von Jonas herunterladen: https://wp-ninjas.de/wptk-mz b) von Birgit Speziell für alle Hörerinnen und Hörer dieser Podcastfolge gibt es einen exklusiven über 50%igen Rabatt auf "Der Wöchentliche Stups" - bleibe ein ganzes Jahr dran an Deinem Online-Marketing und gewinne so mehr Kunden. https://marketing-zauber.de/podcast-goodie (Aktion endet am 31. Dezember 2022 um 23:59 Uhr!) Mehr Informationen zu Jonas' Angebot mit WP-Ninjas findest Du auf dieser Website: https://wp-ninjas.de Wenn Du immer mal wieder Hilfe bei WordPress benötigst, werde doch Mitglied im WP-Ninjas-Dojo hier: https://wp-ninjas.de/wp-ninjas-dojo Wenn WordPress nur manchmal ein Thema für Dich ist, Du aber mit Deinem Online-Marketing und auch der dazugehörenden "Technik" auf Kriegsfuß stehst, werde doch Mitglied im Marketing-Zauber-Zirkel hier: https://marketing-zauber.de/zirkel/

Gas prices are heading straight to the stratosphere. Inflation is the elephant in the room. And there's a growing concern in Medicare when it comes to physician payments. Here's why: Medicare cuts are pending, including the PAYGO 4 percent, starting in 2023.What's more, deductions from reinstated sequestrations are on the rise. There's also an expected lowering of the 2023 conversion factor, the possible ending of the public health emergency (PHE) windfall of telehealth payment parity, as well as MedPac saying that a physician raise generally is not necessary. So, the burning question: where is all the money going from Medicare? For an exclusive backgrounder on this timely and worrisome topic, register now to listen to the next live edition of Talk Ten Tuesdays. That's when nationally recognized physician coder, auditor, and consultant Terry Fletcher will have insight and perspective on the potential impact on your practice, moving forward. The live broadcast will also feature these other segments:Coding Report: Laurie Johnson, senior healthcare consultant with Revenue Cycle Solutions, LLC will report on the latest coding news.Mental Health Report: Internationally recognized and award-winning psychiatrist H. Steven Moffic, MD, will begin a new series on mental health. His focus this Tuesday will be on PTSD, a particularly relevant segment given that June is PTSD Awareness Month.News Desk: Timothy Powell, CPA, a consultant with Besler, will anchor the Talk-Ten-Tuesdays News Desk.Journaling John: John Zelem, MD, FACS, founder and CEO for Streamline Solutions Consulting, will continue with his second journal entry in this new segment.TalkBack: Erica Remer,MD, founder and president of Erica Remer, MD, Inc. and Talk-Ten-Tuesdays co-host, will report on a subject that has caught her attention during her popular segment.Sitting in for executive producer and program host Chuck Buck will be Dennis Jones.

Staffing challenges and cost inflation are seriously impacting health care construction as well as other sectors of the U.S. construction economy. In this episode of our Owner's Outlook series, hear from special guest Mike Noli, founder of the NoliWhite Group. Mike and Epstein Becker Green construction attorney Chris Dunn break down which projects are at greatest risk and how to successfully manage these projects amid the current market pressures. Visit our site for more information and related resources: https://www.ebglaw.com/dhc41. Subscribe for email notifications: https://www.ebglaw.com/subscribe. Visit: http://diagnosinghealthcare.com. The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

In this episode, James shares common mistakes people make with their API Keys and explains the appropriate way to handle them.SponsorsVercelVercel combines the best developer experience with an obsessive focus on end-user performance. Their platform enables frontend teams to do their best work. It is the best place to deploy any frontend app. Start by deploying with zero configuration to their global edge network. Scale dynamically to millions of pages without breaking a sweat.For more information, visit Vercel.comZEAL is hiring!ZEAL is a computer software agency that delivers “the world's most zealous” and custom solutions. The company plans and develops web and mobile applications that consistently help clients draw in customers, foster engagement, scale technologies, and ensure delivery.ZEAL believes that a business is “only as strong as” its team and cares about culture, values, a transparent process, leveling up, giving back, and providing excellent equipment. The company has staffers distributed throughout the United States, and as it continues to grow, ZEAL looks for collaborative, object-oriented, and organized individuals to apply for open roles.For more information visit softwareresidency.com/careersDatoCMSDatoCMS is a complete and performant headless CMS built to offer the best developer experience and user-friendliness in the market. It features a rich, CDN-powered GraphQL API (with realtime updates!), a super-flexible way to handle dynamic layouts and structured content, and best-in-class image/video support, with progressive/LQIP image loading out-of-the-box."For more information, visit datocms.comShow Notes0:00 IntroductionYouTube Video RE: Mistakes People Make with API Keys6:42 API Keys7:37 Where do API Keys come from?8:57 Mistakes People Make with API Keys9:10 Mistake #1: Hard Coding the API Key Value11:45 Sponsor: Vercel12:53 Mistake #2: Adding an API Key to the .env file, but still exposing the key16:20 Mistake #3: Committing Your Key to Source Control17:59 What should you do about a leaked API key?19:38 Using .gitignore21:20 The Best Way to Handle Secrets22:57 Serverless FunctionsEpisode 57 - Authentication and Authorization and other Buzz Words29:55 Sponsor: ZEAL30:41 Where would you put a Bearer Token?31:40 Server Side Rendering33:49 Public API Keys37:20 Sponsor: DatoCMS38:13 Grab Bag Questions38:24 What's the best way to share environmental variables across different machines?38:35 What are the pros and cons of system environmental variables vs a KMS (Key Management System)?40:34 Picks and Plugs40:44 James's Pick: Sketcher's Tennis Shoes from Costco44:54 James's Plug: YouTube Video - 10 Things JavaScript Developers Have Stopped Doing45:26 Amy's Picks: James Clear 3-2-1 NewsletterAtomic Habits, by James Clear46:14 Amy's Pick: Keystone.js on Level Up Tutorials

In part two this ASCO Education Podcast episode, hosts Dr. David Johnson and Dr. Patrick Loehrer continue their conversation with Dr. Richard Pazdur, director of the U.S. Food and Drug Administration's Oncology Center of Excellence, focusing on his leadership and vision for improving cancer care worldwide. The conversation includes reflection on drug toxicities, approval processes, and complexity of clinical trials. If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at education@asco.org.   TRANSCRIPT Dr. Pat Loehrer: Hi. I'm Pat Loehrer, the Director of Global Oncology and Health Equity at Indiana University. Dr. Dave Johnson: And hi. I'm Dave Johnson at UT Southwestern in Dallas, Texas. Dr. Pat Loehrer: This is the second half of our Oncology, Etc. conversation with Dr. Rick Pazdur, who's the director of the FDA's Oncology Center of Excellence. In Part 1, we chatted with Dr. Pazdur about his upbringing and his early career. Today, we're going to focus on his leadership and vision for improving cancer care worldwide. But first, we'll discuss how cancer has impacted his life personally.   I want to flash-forward. I had the pleasure of knowing Mary. And there was no question, if you had a problem in oncology, you would go to Mary and not Rick Pazdur when you were a house staff member. But moving forward a bit, I'm not sure if all the listeners know that Mary came down with ovarian cancer. Dave himself had cancer. My wife had breast cancer. It is incredibly hard to be an oncologist I think when your spouse or someone who's close to you has cancer, and particularly, being married to a medical oncology nurse. Maybe just share a little bit about that journey of being a husband of a- Dr. Richard Pazdur: Yeah. It is interesting because going back to the Rush story, the first patient that my wife and I had in common, and this is so ironic, was a patient with ovarian cancer. The last patient that we had in common was her, which is some ironic fate, so to speak. And the story began of her illness was right around Labor Day. We had gone to Chicago in February driving back from Chicago. I noticed that she kept on taking a whole bunch of Tums and then saying - Oh, I just got a lot of GI symptoms, and she went to see her gastroenterologist or GP and he said, ‘Oh, this is just, you know, indigestion.' And two weeks after that or not even that, she was in the hospital with a massive amount of ascites, needed an intensive care unit. It was readily apparent just on getting her CA 125 what she had and she wound up one day in debulking surgery and then IP chemotherapy, etc. I think something that I learned, and I think we knew from the very beginning that this was not going to be a curable illness, and how to deal with that on an emotional level. And I have to give my wife credit. She spared me a lot of the emotion because she was such a strong person. She made all of her own calls as far as what she wanted. She would ask me what I thought, but she would do her own research, she would go to her own doctors' appointments. She said, ‘You don't really need to come with me. I'm self-sufficient.' She was very much interested in helping other cancer patients, and after she died, I think one of the most cherished conversations I had was a group of women that came to me and said how much she helped them during their support group because she was a nurse. She knew she was dying. She had emotional maturity not to fall apart but to accept the inevitable in a very strong way. My wife was a very religious person, had gone to Catholic schools, really embraced religion during those terminal years basically. And I think that was a great sense of comfort to her. But it did teach me a lot of lessons when you take care of somebody that has cancer, and that is, what a bad job we do with drug toxicities. Drug toxicities to medical oncologists and especially the people at the FDA are numbered, Grade 3, Grade 4, Grade 1. These toxicities are tolerable, tolerable to who, so to speak. And how to manage these toxicities and how they interrupt your life is one of the lasting experience I have, which I always will remember. And that has been one of my roles recently is forming several programs that we have in the OCE to look at dosing, to look at what is this definition if the drug is tolerable or well-tolerated or if the toxicities could be managed. I always say, yeah, every toxicity could be managed, even death. You call the undertaker to manage it. So what do you really mean by that statement. But I think the issue of toxicity is an important one. And then also going on clinical trials and having people considering what you want to go on, what risk you want to take, and what is actually in the informed consent and how meaningful that is. Dr. Dave Johnson: Really glad you brought that up, Rick. That matches my own experience with lymphoma and going through chemotherapy. And as an oncologist, one would think I would know what the side effects are. I'd recounted them dozens and dozens of times to people over the years, but until you've actually experienced them either personally or up close as you did with Mary, it's impossible to fully understand. I'll give you one example. Fatigue. Everybody thinks they know what fatigue is, but until you've had chemotherapy-induced fatigue, the fatigue that never abates, you just don't understand what it is. It's debilitating in ways that are unimaginable to most people. So I'm sure that experience certainly shaped your view and your role at the FDA. Dr. Richard Pazdur: Correct. Dr. Dave Johnson: I wonder, if you might share, you initiated a number of programs recently, including programs to try to improve coordination and co-operation amongst the pharmaceutical companies. Could you speak to some of those programs for us? Dr. Richard Pazdur: I think one of my favorite programs is Project Orbis. Project Orbis is an idea I had when I was walking down the street. It just hit me. When I came to the FDA, one of the things I rapidly noticed is how isolated the FDA was, even from the rest from the regulatory agencies throughout the world. There was very little cross-fertilization there. So one of the very first things that I did was set up a monthly tele-conference first with the EMA, the European Medicines Agency, and then we ended on Health Canada, Australia, Japan, Singapore, you name it. And one of the things that became really apparent to me, we at the FDA got applications always first—always. That's obvious. You know why they had given it to us first? The money. That's where the finances are going to be. So we got the application first, and it could be 2 years, 18 months, 12 months, that these other countries, Canada, Australia, Switzerland, and Brazil, Israel, would get these applications. And I said, well, this isn't right, really, because these people, they have cancer. They have every right to get these medications as soon as possible, and also we have such a large agency. We have 80 to 100 oncologists that work there, and most of these agencies have one or two oncologists. So our expertise in oncology at the FDA is so much greater than these other regulatory agencies. How can we leverage that to help these other countries? So we started Project Orbis, and what it was is that companies come in and they submit an application and they simultaneously submit the same application to the countries that want to participate in the program. They are all preselected and have confidentiality agreements with each other. And we worked together on the applications, basically reviewing the applications. So we had many meetings, tele-conversations, telephone conversations with countries. So that expedites these drugs. This has really had a lasting impact because from a worldwide perspective, it's really promoted more rapid development of drugs and rapid approval of drugs, and that's important because that establishes sooner new standards of care that will impact future trials. So in addition to the humanitarian issue of improving healthcare for patients in these countries, it has an impact on the global clinical trial system by having new standards approved much faster and accepted by world authorities. Dr. Pat Loehrer: Let me just jump on that for a second, just to make a comment. Back when we were growing up, there would be like three to five drugs approved- Dr. Richard Pazdur: Yeah. Dr. Pat Loehrer: And today, it's like once a week, there's a new indication for oncologists. Dr. Dave Johnson: Our listeners have another question that might be appropriate to ask at this time. What is the most common mistake that drug companies make in their applications to the FDA or in the process of trying to get their drug approved? Is there a frequent mistake that you can advise them? Dr. Richard Pazdur: Well, they don't come and talk to us. That's number one. They want, not necessarily what the best registration pathway is, but what the quickest registration pathway is. And sometimes the quickest registration pathway, especially single arm trials, are not the best registrations pathway. So my advice is rather than playing games with the FDA, to put it in the vernacular, just do the right thing and say, what is the optimal information that patients need when I develop this drug. We're seeing a lot of problems now with various drugs where people are developing in a refractory disease setting a drug, and they plan on getting accelerated approval on a response rate. So they push and push the dose. And with a single arm study, you can't really evaluate safety that well. Everything is attributed to the drug, and they want to get the highest response rate. And they get it, and there's a confirmatory study, and the arm of the confirmatory study, the control arm may not be as toxic as theirs, and we're seeing a wave of drugs that now have inferior survival compared to controls, which probably is predicated upon, they got the wrong dose. And I think that is one of the major programs that we have, that we need to address is dosing in oncology, this ‘More is better, more is better,' and ‘Let's push the dose as high as possible.' More isn't even probably good in cytotoxic days, but certainly, not a good idea in targeted therapies and certainly not a good idea in biological therapy. So we've really got to think about dosing more, penetration of targets, what's the optimal dose rather than what's the highest dose. You know as well as I do, pharmaceutical companies want to go with the highest dose because the major hurdle is the demonstration of efficacy, even in a randomized study. So nobody wants to be blamed by saying, well, you spent $100 million on a Phase 3 study and it's negative because you used too low of a dose. But then at the end of the day, we don't have a really good tolerable dose, and it's really hard to go backwards and look at dosing after a drug was already approved because the efficacy study has already been done. Dr. Pat Loehrer: The other aspect of drug companies is not only getting the dosage there, but also the duration. There is motivation for money, and so patients are going to and- Dr. Richard Pazdur: Oh, count on that. Dr. Pat Loehrer: So it begs a question, and I know the FDA can't do this, but in other countries, there is a monetary review together with the toxicity review. Can you reflect a little bit about that to the best of your ability? Dr. Richard Pazdur: Well, even within our simpler agencies, they may communicate more than we do with CMS, but all oncology drugs that when they're approved are then paid for by CMS, okay? In these other countries, that is not so. They may get approval and then they have to go to these health assessment agencies that will decide and argue with the companies what the pricing of the drug is. I think it's a mistake, honestly, for the FDA to get into pricing. We have a hard enough time with efficacy and safety, and pricing is a very ephemeral concept because it could change on a dialing. Somebody could promise you, you should approve their drug because it's much cheaper on Monday, and on Friday, they could say, 'Oops, we made a mistake. We really think that this dose has to be X number of dollars.' And you could see competition hasn't worked well in oncology with seven PD-1 drugs approved, pricing has not really been of any movement here. Dr. Pat Loehrer: I'm sorry. Dave may have another question, but let me ask you this. Going back to the clinical trials and what industry asked you- the complexity of clinical trials is going up logarithmically compared to the way they were in the ‘70s and ‘80s. In many of the trials where we have to get all this data in order to soothe the FDA, what are your thoughts about simplifying clinical trials? Dr. Richard Pazdur: Oh yeah. I'm for it. I am for it. If you really look at it, these are not FDA requirements for the most part. The companies want them, all of this data because it's controlled. They don't want to be blamed at the end of the day for not capturing this data or that data. They have developed complicated bureaucracies, going back in my sociology days there, complicated bureaucracies to gather all of this data, the whole CRO industry to go out and pester you guys in practice by doing site visits. It's a complicated situation and it's really predicated a lot on the history and bureaucracies that have been built up and not money to strip away those bureaucracies for fear of failure, so to speak, of not catching something. Dr. Dave Johnson: So Rick, we're coming to the end of our time that we've scheduled. I actually have two questions for you. We've asked all of our previous guests, the first of which would be if you could talk to your 21-year-old self today, what advice would you give yourself? After you've done that, we'd like to know what books have you been reading lately or is there some documentary that you've seen that you would recommend to us and our listeners? Dr. Richard Pazdur: I would tell myself, when I was 21 years old, relax and be less anxious. All things pass. I think we get so anxious when we're young about relatively small things. I remember my first ASCO presentation, I was petrified. My heart was beating out of my chest. I was sweating. And like relax. It's one of a thousand presentations at ASCO. We tend to magnify things, and I think age puts things in perspective. This in the reality of the world is a small thing, and people probably won't even remember it. Dr. Dave Johnson: Excellent advice. Dr. Richard Pazdur: My favorite author that I'm reading now for the last couple of months is a presidential historical author, Doris Kearns Goodwin. I think many of you know, she's written many books. I love her writing style. And I like non-fiction. I like biographies and I like history books, history stories rather than mysteries or things like that, fantasy books. The two books that I really enjoyed, the first one was No Ordinary Time: Franklin and Eleanor Roosevelt: The Home Front in World War II. I don't know if anybody's read that. It's an excellent book. Most of our attention in World War II is directed toward Europe and what was going on in Europe, the battlefields, etc., which I'm not a big fan of reading about battles and stuff, but this was what was going on in The White House and the relationships of all of the people that came there. It was like a hotel almost with the personalities that were flowing through including Churchill and various princes and queens, etc. But also the interesting relation, the fascinating relationship that Eleanor and Franklin Roosevelt had, I don't know how to describe the relationship. It truly was an unconventional relationship based on some past history that they had of affairs etc., but it was just a fascinating one. The best book, though, again I'm reading now, is written also by Doris Kearns Goodwin, and it is Lyndon Johnson and the American Dream. Doris Kearns Johnson was his biographer and spent a great deal of time with him in The White House as well as when he left The White House. But it's an excellent book on management and reading people, success. One of the things that is most interesting about Lyndon Johnson, and especially when he was running the senate before he became president, was his ability to know what motivated people and how to use that to form a consensus. Does this person want to go on this trip. I'll give it to him and then he could help me with this. Does this person want to go to this party or get on this position in congress? So it was really a skillset that he had, which I think most leaders need to know. You have to motivate people. You can't lead by an autocratic masthead, but you've got to lead from what do people want and to make sure that they feel you have a personal relationship with them. As I say to my staff, everything in life is personal—everything. Dr. Dave Johnson: Well, it's been a great session, Rick. We so much appreciate your willingness to spend time with us. We wish we had twice as much time. I'm sure we could go on for hours. Thanks again, and we appreciate all you do at the FDA. You've been a fabulous leader, and we hope you continue on for many years to come. Dr. Richard Pazdur: Thank you so much, Dave, and thank you so much, Pat. Dr. Pat Loehrer: Great to see you. Dr. Dave Johnson: Pat, before we leave, any idea why our patients seem to get sick on Saturday and Sunday? Dr. Pat Loehrer: I have no clue. Do you know the answer, Dave? Dr. Dave Johnson: Yes. They have a weekend immunity. Thank you for listening to the ASCO Education Podcast. To stay up to date with the latest episodes, please click subscribe. Let us know what you think by leaving a review. For more information, visit the Comprehensive Education Center at education.asco.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.    

New price transparency rules from the Centers for Medicare & Medicaid Services required hospitals and hospital-owned organizations to post machine-readable files in plain language that will allow patients to generate estimates for what they will pay for a given medical service. By using the healow Price Transparency tool, medical organizations can comply with CMS rules and gain a competitive advantage by attracting business from consumers who want to know upfront what their out-of-pocket costs will be. For more information book a meeting here: https://meetings.hubspot.com/kshogren 

This week I talk about having a Starter Site [powerpress]

In the latest episode of On the Case, Jess Harrold is joined by Martin Garner, partner at CMS, to discuss the first disputes under the Electronic Communications Code to reach the Supreme Court:  Cornerstone Telecommunications Infrastructure Ltd v Compton Beauchamp Estates Ltd and conjoined appeals [2022] UKSC 18; [2022] PLSCS 99. Garner explains the operation of the Code, the issues that led to the three cases concerned here, and how the Supreme Court determined the appeal. In addition, he addresses the implications of the decision for landowners and telecoms operators, and outstanding issues under the Code that will continue to occupy the higher courts.

Video evidence of repairs, filter changes, and installations is becoming the norm. And, video evidence is much better than CMS, convenient memory syndrome. Aaron Salow, CEO of XOI Technologies. A leading company in Intelligent Field Service Communications, gives you an easy way to have this video evidence. Podcast Sponsor is Profitability Movement - https://profitability-movement.mn.co Ruth King Twitter - @RuthKing LinkedIn - https://www.linkedin.com/in/ruthking1/   Podcast Produced by Nick Uttam https://www.linkedin.com/in/nick-uttam-4b33a1147

CMS's Hospital Quality Measurement and Value programs have shaped the hospital field and given patients information to inform their care for over 15 years. But a once in a lifetime pandemic has had a profound impact on how those programs operate. On today's podcast, we'll discuss what happened with these critical programs during the pandemic and where CMS can go from here. Joining this [Special Edition] podcast to discuss is Akin Demehin, Senior Director of Quality and Patient Safety Policy with AHA. This podcast was recorded live at the AHA Annual Meeting.

Some three years after the government first announced it's intention to abolish section 21 notices under a Renters' Reform Bill, it has published it's white paper on reform of the private rental sector. To help explain the proposals is Eleanor Murray, partner and head of residential disputes at law firm CMS, who sets out the rationale for change, what the government is proposing as part of its “12-point plan of action” and what landlords can be thinking about now in advance of change being implemented.

As part of Pride Month, listen to Health Affairs' Jessica Bylander and Kathleen Haddad discuss the White House's executive order on LGBTQI+ equality and its impact on health care.Related Links: Privately Insured Transgender People Are At Elevated Risk For Chronic Conditions Compared With Cisgender Counterparts (Health Affairs) Podcast: A Health Podyssey with Landon Hughes Lesbian, Gay, And Bisexual Adults Report Continued Problems Affording Care Despite Coverage Gains (Health Affairs) The Battle Over Gender Therapy (The New York Times Magazine) 2022 National Survey on LGBTQ Youth Mental Health (The Trevor Project) Currently, more than 70 percent of our content is freely available — and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

CMS has a free online course called "Improving Health Care Quality for LGBTQ People." Here’s 4 reasons you should take it! I'm grateful that there are so many resources out there if you care about health equity and communication. In honor of Pride month, I'm going to highlight one of them: a free online course […] The post 4 reasons to take the free CMS course on LGBTQ health appeared first on Health Communication Partners.

It's almost time for NAHU's Annual Convention! But, before we see your bright smiling faces in Austin, there is some regulatory news to discuss! This week, NAHU submitted comments to CMS in response to a proposed rule released in April that makes policy changes to the Medicare enrollment process, among other important changes. On this week's episode of the Healthcare Happy Hour, NAHU's John Greene discusses our comment letter to the administration. Additionally, we discuss how you can complete your Medicare Advantage training with NAHU.

https://www.youtube.com/watch?v=Bd21JObzQeI Show Notes Today we venture into the bizarro world of Medicare (the program serving those 65 and older as well as some people with disabilities) to explore the largest Medicare rate hike in history. Our guest Alex Lawson, the Executive Director of Social Security Works, will help explain what's happening. Social Security Works is the convening member of the Strengthen Social Security Coalition, which represents over 50 million Americans. SSW fights to protect and expand Social Security, Medicare, Medicaid, and to lower prescription drug prices. Today we venture into the bizarro world of Medicare (the program serving those 65 and older as well as some people with disabilities) to explore the largest Medicare rate hike in history. Our guest Alex Lawson, the Executive Director of Social Security Works, will help explain what's happening. Social Security Works is the convening member of the Strengthen Social Security Coalition, which represents over 50 million Americans. SSW fights to protect and expand Social Security, Medicare, Medicaid, and to lower prescription drug prices. Today we're talking about the massive increases in Medicare Part B (physician and outpatient services) premiums for this year. Hospital care is called Part A, and once you're eligible for Medicare you can get hospital coverage automatically. BUT for Part B, you have to pay a monthly premium - just like a private health insurance plan. There's a super shady history behind this!  The origins of the Part B premium go back to the Jim Crow era. When Medicare was first implemented, some in the South feared that Federal law would require the integration of physician offices. By requiring a premium, Part B would be a "voluntary" program and integration requirements wouldn't apply. This allowed physician offices (as well as nursing homes) to remain segregated much longer than hospitals. In 2022 Medicare Part B premium rose 14.5%, from $148.50 to $170.10 PER MONTH ($21+ increase), and the annual deductible rose from $203 to $233. For perspective, the Part B premium was less than $50 back in 2000, and there was only a $3.90 increase last year. This is the LARGEST premium price hike in Medicare history. For most American seniors, those premiums are deducted right out of their Social Security checks. For an American senior who depends on Social Security benefits of an average of $19,000 a year, those increases mean a significant cut to their income. A senior living on an income 175% of the poverty level will spend nearly 9% of his/her income this year on Part B alone. This comes down to Biogen's new Alzheimer's drug, Aduhelm. Regardless of the fact that this drug failed, Biogen put all their eggs in the Aduhelm basket. They corrupted the Food and Drug Administration (FDA) to get it approved, despite the fact there is no evidence it is effective and it can actually cause brain bleeds and death. Aduhelm is so expensive that it accounts for at least 50% of the Part B premium increase.   The drug itself initially cost $56,000(!) for one person; the price was slashed in half by Biogen because of low demand. The other costs associated with the treatment are charges for the infusion of the drug and charges for the regular brain scans that are required while taking the drug. Those brain scans are to monitor progress of the treatment, but also to make sure your brain isn't swelling up, which is a side effect 35% of clinical trial participants experienced. It's estimated that only a small fraction of Medicare beneficiaries will use this drug, which, remember, doesn't work. But to make more profits for Biogen, American seniors' premiums went up more than they ever have.   Right off the bat, the Veterans Administration declined to cover Aduhelm. Many private insurers are also limiting approval of Aduhelm. CMS - the Center for Medicare and Medicaid Services - usually follows the lead o...

Practices have just to the end of the year to prepare for and adjust to the new CMS billing guidelines that include rules around split/shared visits between physicians and advanced practice providers (APPs). On this episode of Modern Practice, we'll continue our discussion about these 2023 guidelines and examine tactics you can use to improve your performance under them.   Guest speakers: Christen Hunt, DNP, NP-C, CPNP-AC Senior Director Clinical Team Insights Vizient   Jennifer Sarno, MSN, ACNP-BC, CPHQ Programmatic Advisor Director Clinical Team Insights Vizient   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Principal Clinical Operations and Quality Vizient   Show Notes: [00:45] A laundry list for getting prepared [02:43] Need for awareness among providers [03:10] Need for organizational assessment [03:46] Areas covered by the new ruling [04:27] No blueprint [05:43] An opportunity for efficiency [07:04] Importance of documentation [08:09] Modifier required [08:40] Challenging the status quo [09:00] Vizient's role to help organization's prepare   Links | Resources: To contact Modern Practice: modernpracticepodcast@vizientinc.com Christen Hunt's contact email: christen.hunt@vizientinc.com Jennifer Sarno's contact email: jennifer.sarno@vizientinc.com Calendar Year (CY) 2022 Medicare Physician Fee Schedule Final Rule (CMS) – includes information on 2023 split/shared visits Click Here   Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify Stitcher RSS Feed  

Sitefinity Design Services Laravel is one of the most popular PHP frameworks on Github. Companies like Coca-Cola and Mercedes Benz use Sitefinity to power their websites.  They make it easy to manage your website in a highly responsive manner for mobile development. Sitefinity isn't perfect, but it goes toe-to-toe with any other CMS platform on the market.  For businesses willing to pay a premium, it can supply everything they need. We have a team of skilled developers and Sitefinity consultants standing by ready to serve you. More info about sitefinity development services:   https://dev.co/sitefinity/   Connect with us:  SEO // PPC // DEV // WEBSITE DESIGN

We have switched over to Slack from Discord. News There has been a lot of feedback for full site editing in the latest release of WordPress. The team over on make.wordpress.org is looking for people to sign up for usability testing by June 24th. This outreach program is going to try something new and pair up members of the program with community designers. Once paired, they will then find time between June 20th and July 1st to record a 15-minute call on Zoom going through one of two tasks: Creating & applying a new header, and using and customizing patterns. WordPress.org is now strongly recommending that theme authors switch to local hosted webfonts. Sarah Gooding writes over on WPTavern that a recent German court case fined a website using Google-hosted webfonts. In order to comply with GDPR - Europe's General Data Protection Regulation - WordPress themes should switch to locally hosted webfonts. Are you still recovering from WCEU? There are two reviews from media supporters that you may want to check out. Bob Dunn and Matt Medeiros recorded their experiences. And there are nearly 3000 event photos. If you would like to see those you can view the photo album from WCEU on Flickr. Andrew Palmer reviews his WCEU experience right here on the WP Minute. Nathan Wrigley interviews Matt Mullenweg on the Jukebox podcast hosted at the WPTavern. Mullenweg shares his reflections on WordPress and the changes to come in the future. WooCommerce: WooCommerce 6.6 was released and you can find the complete changelog over on the WooCommerce site for the recent changes. From Our Contributors and Producers Eric Karkovack writes about the CMS landscape (including WordPress) on the latest at the WP Minute. Eric makes a good argument about why a freelancer would not choose WordPress for building a website. What's with the WordPress vibe? Changes and Acquisitions seem to be published weekly now. Acquisitions in #WordPress have created some concern among smaller businesses and entrepreneurs as we compete with bigger companies with much larger budgets. Mark Zahra has a little survey on Twitter asking if you had to double down on one area in the next 6 months with the goal of generating growth, what would it be? There were several layoffs reported lately from Elementor and Envato. James Giroux tweeted about the status of @envato and @elemntor announcing significant redundancies in the last week. You can help those affected by: 1. Celebrating wins publicly and calling out individuals by name 2. Adding to their LinkedIn profiles 3. Introducing them to your network Next Up: Simplified Business Minute by Sam Muñoz The Case for Not Automating Client Interac

Tune into the second episode in the Avalere Health Essential Voice podcast series focused on the how CMS and Medicare coverage decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs)that have coverage with evidence development (CED) requirements, how FDA and CMS's evidence questions can be complimentary, and the ways in which manufacturer evidence generation plans can address those goals, using the NCD on monoclonal antibodies for Alzheimer's disease as an example.

David Dean joins us to tell us a tragic story about the time he spent in Ireland with John Senior and 100 students. However, there was a beauty that came from it that will bring you to tears when you hear it. http://www.patreon.com/thecatholicmanshow (Become a Patron! Over 40 interviews, a course with Karlo Broussard, a 10 part series on the domestic church, a course on fitness and virtue by Pat Flynn, and free thank you gifts for supporting the show!) https://selectinternationaltours.com/catholicmanshow/ () WE ARE GOING TO IRELAND WITH FR. SEAN DONOVAN AND THERE ARE STILL A FEW SPOTS LEFT! JOIN US – https://selectinternationaltours.com/catholicmanshow/ (MORE DETAILS HERE). About our drink: N/A About our gear: N/A About the Topic: John Senior. The Integrated Humanities Program. Ireland. Death. Sorrow. Beauty. Poetry. This is what's discussed in this week's episode. This episode is sponsored by: https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS (CHRIST CENTERED CAPITAL) We point out what companies, organizations and charities are aligned with Christian Values, and which are not, so you can make morally informed decisions on what to do with your capital. https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS (Use promo code TCMS2022 for a 1 month free subscription. ) https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS () http://exodus90.com/tcms (What's your holy hour look like? ) There's a common thread among thousands of formerly sinful people we now call Saints. They had a relationship with God. Which then inspired them to ‘set the world on fire' as Catherine of Sienna put it. But, more specifically, it meant they put in the time. They sat with the Lord. Spoke with Him. Listened to Him. Daily. They unveiled their hearts and wounds and problems to Him. They offered him thanks and gratitude. They left their sufferings with Him on the altar. They begged for His help. My question to you: are you putting in the time? I'm not talking about time to just talk at Him or sit in church making a mental grocery list. I'm talking about time to build a consistent, honest relationship. Time to speak, and time to listen. Whether you want to pray a daily holy hour or hit up adoration once a week, I have a guide here from the makers of Exodus 90 specifically about praying a Holy Hour. Inside, you'll find a simple breakdown that shows you how to structure your time with the Lord. You can grab the mobile-friendly guide for free at http://exodus90.com/tcms (Exodus90.com/tcms) TIME CODES: If this is your first time listening to The Catholic Man Show, we do 3 things almost every episode:1.) Open, review, and enjoy a man beverage – Minutes 1-12.2.) Highlight a man gear – Minutes 12-24.3.) Have a manly conversation – Minutes 24-48If you haven't listened to The Catholic Man Show before, check out our previous episodes https://thecatholicmanshow.com/episodes/ (here). Subscribe to our https://www.youtube.com/channel/UC5MhmMZZhEnrapVYUIkFHLg?view_as=subscriber ( YouTube channel) to watch past episodes. Want to help The Catholic Man Show? By giving us a rating on https://itunes.apple.com/us/podcast/the-catholic-man-show/id1128843873?mt=2 (iTunes, it helps others find the show.) Want to say up with The Catholic Man Show? Sign up for our mailing list: http://www.thecatholicmanshow.com/manly (Click Here) Looking for a prayer to pray with your wife? https://thecatholicmanshow.com/blog/looking-for-a-prayer-to-pray-with-your-wife-print-this-off-and-start-praying/ (Check this blog out.) Are you getting our emails? Sign up for our newsletter where we give you all bacon content – never spam.  http://thecatholicmanshow.com/manly/ (SIGN UP HERE:)...

In today's episode, hosted by the EBB Research Team, we are sharing the audio from a private livestream we did with our Pro Members at Evidence Based Birth. We talk about three major topics related to updated research evidence on doulas: 1) research on the pandemic's effect on the doula profession around the world, 2) research on the difference between community-based doulas and private or traditional doulas, and 3) new info on paying or getting reimbursement for doula care in the U.S. [NOTE FOR LIBSYN ONLY]: This podcast is also posted on our YouTube channel in case you want to access the video of our team teaching, and a screenshare of some of the evidence we're talking about! As a content note, this episode includes discussion of COVID-19, racism, and how a lack of postpartum coverage is in some cases tied to the same places that have abortion bans. Today's episode is taught by Rebecca Dekker, PhD, RN (she/her), Ihotu Ali, MPH (she/her), and Erin Wilson, MPH (she/her). Dr. Dekker is a nurse with her PhD who is the founder and CEO of EBB. Ihotu is a community-based doula, Maya abdominal massage therapist, doctoral student in chiropractic medicine, director of the Oshun Center for Intercultural Healing, and Research Editor at EBB. Erin is a clinical researcher, doula, childbirth educator, policy advocate, and Research Editor at EBB. Together, we will share with you some research we were compiling about the evidence on doula care!   Content warning: Discussion of the COVID-19 pandemic, racism, and how a lack of postpartum Medicaid coverage is in some cases tied to the same places that are issuing abortion bans.   Resources: For a full list of scientific references, see the blog post that goes along with this episode Check out our Signature Article... Evidence on: Doulas at https://evidencebasedbirth.com/doulas The Sista Midwife Productions Black doula/midwife directory is here: http://www.sistamidwifedirectory.com/ Go to our YouTube channel to see video versions of all our podcasts! (including PowerPoint presentations when used) Check your state's status on whether or not they're funding doulas through Medicaid here: https://healthlaw.org/doulamedicaidproject/#:~:text=Read%20the%20Report-,Current%20State%20Doula%20Medicaid%20Efforts,-The%20National%20Health Check your state's status on whether they're expanding Medicaid postpartum here: https://www.kff.org/medicaid/issue-brief/medicaid-postpartum-coverage-extension-tracker/ Donate or apply for the Hello Seven doula fund for Black families here: https://helloseven.org/ If you support this work, we encourage you to use your voice and speak up, and to caution against low reimbursement rates and expensive licensure/certification processes that have created barriers to entry in certain states that are actively reimbursing doulas. We at EBB want to see all doulas earn a living wage, regardless of which type of clients they serve (Commonwealth Fund: Issue Brief, 2021). Doulas can apply for a National Provider Identification (NPI) number. Here is a guide on how to apply and here is a link to the application through CMS. If you can get an NPI, it will increase your chances of getting paid through insurance/help your clients receive insurance reimbursement. For more information and news about Evidence Based Birth, visit www.ebbirth.com . Find us on Facebook (https://www.facebook.com/EvidenceBasedBirth/ ), Instagram (https://www.instagram.com/ebbirth/ ), and Pinterest (https://www.pinterest.com/ebbirth/ ). Ready to get involved? Check out our Professional membership (including scholarship options) (https://evidencebasedbirth.com/become-pro-member/ ). Find an EBB Instructor here (https://evidencebasedbirth.com/find-an-instructor-parents/ ), and click here (https://evidencebasedbirth.com/childbirth-class/ ) to learn more about the Evidence Based Birth  Childbirth Class.

The 16:9 PODCAST IS SPONSORED BY SCREENFEED – DIGITAL SIGNAGE CONTENT The prevailing impression of Google and digital signage is that the tech giant came briefly into the sector a few years ago, made some noise, and then quietly left. But the reality is that the tech giant has continued to be active in digital signage, and there are numerous screen  networks out there running on Chrome OS devices through different CMS software vendors. Then there's Android, the Google-developed operating system used on a pile of smart displays and separate play-out boxes. But now Google is again getting visibly active in the digital signage and related kiosk ecosystem, extending an existing program called Chrome Enterprise Recommended to software vendors who use Chrome OS. It's also introduced a Chrome OS device management license,  for narrow-purpose uses like screens and kiosks, that works out to just a touch more than a couple of bucks a month. And there's Flex, an application that can extend the life of a Windows box by running Chrome, and enable screen networks using a blend of playback hardware. I think a lot of the early interest in Google, back in 2015, was with the relatively low prices of the software and hardware. These days, it likely has more to do with scale, manageability and security. I spoke with Naveen Viswanatha, Google's product lead on Chrome OS. Subscribe to this podcast: iTunes * Google Play * RSS TRANSCRIPT Naveen, thank you for joining me. What's your role at Google?  Naveen Viswanatha: Hey, thanks for having me. I am the Chrome OS Product Lead for our solution areas and our solution areas include virtualization, contact center, and very recently we've beefed up our kiosk and digital signage solution area.  Are you at the main campus out in Silicon Valley?  Naveen Viswanatha: I am, indeed. Yeah, right here in the heart of the main campus in Mountain View. How long have you been with Google? Naveen Viswanatha: I have been with Google for 16 years but I haven't been spending the whole time in Chrome OS. I've been using Chrome OS for about 7 years, I believe. So you're almost a lifer in Google terms?  Naveen Viswanatha: I guess so, it seems like that.  I'm gonna talk about Chrome OS. Can you give me a sense of the installed base globally for Chrome OS? I don't need like today's number, but just like … it's many millions, right?  Naveen Viswanatha: Yeah. We don't break out specific details, but yeah it's in the millions and that kind of spans, I would say across three broad areas. Education is one area. So students and student Chromebooks and boxes. Consumer, and then Enterprise and, within Enterprise, that's where my focus is in the solution space. So yeah, that's how we look at the overall market, but yeah it's seen a tremendous amount of growth, especially in the last several years. Yeah, the pandemic really put a push on Chrome for Education, right?  Naveen Viswanatha: It did. I would actually say that it increased an already healthy appetite for Chrome devices within the education space. I actually used to be part of the education team, and we went from devices that were primarily purchased by schools and districts to devices that were now starting to see adoption in the home and that was the kind of recent trend that we saw over the course of the pandemic is really devices being used in the home, remote for delivery of curriculum.  Would that be driven in part by just the simple fact that the kids are learning at home now, and the parents are seeing the Chromebooks and thinking, okay these are perfectly workable laptops? Naveen Viswanatha: That's entirely right, and in addition to that, some of the unique capabilities allow students to use their education profiles. So the same profile that they use on their Chromebooks at school, they can log into a personal Chromebook at home and all of their data, all of their bookmarks, their applications, everything is synced to them pretty uniquely. And so, that ability of having this kind of floating cloud profile was another reason that it became really easy to simply adopt Chrome devices at home.  Okay, so on the enterprise side, you know, this is a digital signage podcast so we talk about digital signage. I assume that relative to education and to consumer, the percentage of the installed basis for digital signs of kiosk would be still pretty small, right?  Naveen Viswanatha: It's smaller. It's growing though, and in fact, I would actually say that we saw a lot of acceleration, arguably more acceleration broadly in the Enterprise space, over the pandemic in terms of growth, relative to the other verticals I was talking about, and a lot of that had to do with unique capabilities of Chrome that aligned really well with some of the challenges that businesses had during the pandemic to really maintain business continuity, whether that was remote work or whether that was increased concerns around security, data protection due to being remote.  These are all things that Chrome OS was really designed for, and so over the course of the pandemic, we saw a huge acceleration in these trends, and as a result Chrome OS was really the platform and endpoint of choice for many organizations. When I wrote last week about the announcement that, of the the recommended track for kiosk in digital signage. I said that Google made a big splash in the digital signage space in 2015. They took a big booty in the middle of the primary trade show for the industry and had all kinds of people looking at that booth and going, “oh, interesting, these guys are involved. I wonder what that means and will they take over and so on…” and it didn't really happen, there would be suggestions that Google got into the space and then got out of the space but what I wrote was basically, maybe they stepped back a little bit visibly, but they've continued to be in the digital signage and kiosk space and have a pretty decent footprint that isn't known.  Is that a fair statement?  Naveen Viswanatha: I think that is a fair characterization and I'm glad you brought that up because, as we've seen the trend over the course of the last couple of years, some of the trends that I was talking about with regards to the pandemic, those trends around moving to cloud and web are significant. Those trends in moving to remote and hybrid work are significant, increased data protection and controls are significant, and that primarily those three things really accrue primarily to end user computing so Chrome books and Chrome boxes used by employees.  But in addition to that, I think this kind of ties back to your point, we did see a lot of interesting trends as people started moving back into physical spaces. So increased expectations from customers for self-service options, increased expectations from employees for more engaging physical environments when they do return to the office, and these kinds of latter two trends are unique to kiosk and digital signage. So that's where we started really leaning more into this business that we have had for some time, as you mentioned, but really on the backs of what our customers and our partners were doing and what we're seeing as broader trends, we really wanted to lean into this area and really help drive more growth and drive more value into the overall ecosystem znd so recently we have really beefed up our efforts around kiosks and digital signage.  You know, when you work in a very niche industry like digital signage, you have this distorted idea that it's actually a pretty big industry, but in the the overall scheme of things, it's tiny, and I wondered if Google, going back a few years, looked at digital signage and continued to look at it and thought this is interesting stuff.  Signage and kiosks, it's got some possibilities, but it's so small compared to education. How much focus have you put on it? Naveen Viswanatha: I think that's a fair question. The reality, I think is that we have always maintained that we want to be an enterprise computing platform, or commercial, basically anything that requires a business or an organization or an NGO or a government to purchase devices and be the primary buyer. So it's a very broad space, and over the last several years, we have endeavored to really beef up our capabilities around end user computing. That was somewhat timed coincidentally with the pandemic. So that was an area of focus for us starting in 2018-19, really to emphasize these focuses on these solution areas, as I was mentioning, to really go after distinct sections of the enterprise market, and then very recently, starting to invest in kiosk and digital signage because we're starting to see additional trends driving that and those trends being lined up with ChromeOS capabilities. So I wouldn't say it was due to the size of the market in particular. I think it's just in terms of when we think about our overall strategy and where we saw our customers really taking the platform, we wanted to really lean into those areas, and so that's really been the main driver is trying to meet our customers where they are, and identify areas that have a strong product market fit in the enterprise space and you see that as a reflection of the key solution areas that we're investing in, including kiosks and signage now.  So when Google as a company takes an interest in something like this, how does that manifest itself in real terms? Is there like a dedicated team or is this one market that a broader Chrome OS team pays attention to and puts some work into? Naveen Viswanatha: That's a really good question. So I keep referring to these solution areas and maybe it'll help a little bit because I think that'll help frame the answer to your question a bit more to talk about what these solution areas are.  A few years ago we started looking at where we were seeing product market fit and where we were seeing our customers adopt Chrome OS beyond education, and really noticed that to deliver a robust solution built on top of this platform, you really needed to have an end to end solution that customers and organizations knew was just gonna work and work really well, and so what that meant was there's really four components to these solution areas. So there's underlying features and capabilities of the operating system itself, so security, APIs, core functionality that the operating system provides, even for enterprises, things that are unique to the solution areas and I can list off a few new features and capabilities that we have as an example that are unique to the kiosk and signage solution area but that's another part of that.  The second component is around management. So how can these solutions areas and their administrators and the folks that manage these solutions, manage the platform easily? And then there's an ecosystem component to this too, and this is really what I think rounds out our notion of a solution area. An ecosystem includes devices so endpoints and OEMs, as well as peripherals and then ISV partners. So solution providers that actually build their products on top of Chrome OS and we ensure that they're optimized and integrated into the operating system. So that's what constitutes a solution area, and as we saw increased focus and investment in those solution areas, we started really orienting our teams to deliver against that.  On the product and engineering side and the UX side within Google, that means that we still rely on broad platform capabilities that you think of more as foundational layers, but increasingly we have teams that are focused on delivering features capabilities, management capabilities, specific to solution areas. And we'll talk a little bit about that or what we did for the kiosk, and then in addition to that, we really started focusing our partner teams on the partners, both the devices, peripherals, as well as ISV partners that we wanted to work with to really bring these solutions to life, and so there's increasing focus around these areas and we're really organizing ourselves across the stack to really deliver towards these solutions. So you have this Chrome enterprise recommended track for “kiosk and digital signage”. When I saw that, I wasn't familiar with it and I thought, okay, they've created this, but in doing a little bit of digging, it looks like you have Chrome enterprise recommended tracks in other areas already. So this is something you already do and you've added digital signs and kiosks?  Naveen Viswanatha: Yeah, that's exactly right. The solution tracks that you saw prior to the recent announcement for the kiosk track were really built around the end user computing growth that we were seeing in the last several years that I was alluding to earlier, and very recently, last week we announced the kiosk and signage Chrome enterprise recommended solution track, and so nine partners that we worked with, their solutions are validated, they're optimized, they're integrated into Chrome OS. That means that our partner engineering teams have worked with these organizations to ensure that everything that they build on our platform works. They are regression tests every release that comes out. So we're really tightly working with these organizations, and we only expect, especially in the kiosk and signage space, this category to grow over the coming quarters and years.  And this whole validation process, is that to keep your engineers sane or is it in certain respects, a marketing tool to say this is kind of Google approved and Google validated? Naveen Viswanatha: It's a bit of both actually. We actually go through and test these solutions within our own test labs, and then these providers also will be testing their solutions with every Chrome OS release, and as a result of that, we badge these providers, these ISV partners of ours, and that badge effectively denotes that level of confidence for any organization that's going to adopt an end to end solution. Some of the companies that are involved in this are pretty small in relative terms. Are they getting involved, to use a term a colleague of mine used to use, “to bask in reflected glory that we're working with Google” or have they made a business decision based on the technology that this is where things are going and we wanna get ahead of it? Naveen Viswanatha: I've spoken to many of these partners and really a lot of it boils down to their alignment either from a business or technology standpoint that they want to really align their solutions with a platform that they feel is going to help them scale their business. These are organizations that are typically developing web-based applications that are lightweight, robust and work well on Chrome as a web-based operating system. Security is a big concern for them, and I think it's a growing concern in the signage space. We've spoken to many customers having concerns about their screens taken over. If you have more and more screens in your physical spaces, your brand and your operations are potentially at risk, and so a lot of these partners kind of align to that element of Chrome, and I think the simplicity in being able to remotely manage devices, that's another area that these partners have really embraced and benefited from.  So I think it's really around looking at what technology and platform they want to align with and that's where we've started our conversations with them and as you mentioned they represent a specific segment of the market, and I think over the coming quarters and years, we're really looking to add more partners to our kiosk and signage Chrome enterprise recommended track. I got a sense back in 2015 that when the first iteration of this came out and you had a whole bunch of partners really quickly that a lot of the energy and interest around Chrome devices was, here's low cost management software and relatively low cost playback hardware versus the PCs that were out in the market then and it was just at a point when you were starting to see set top boxes and things like that being used.  I sense that's changed, that the partner marketplace is a lot more sophisticated, and as you've alluded to, they're looking more at things like security and ease of management?  Naveen Viswanatha: A hundred percent, that is absolutely right. The kiosk and signage landscape has shifted dramatically, I think, in the last, 18 to 24 months really, kind of emerging out of the pandemic as well, and I think it was shifting before and then I think what happened was that a lot of physical spaces started really being underutilized during the early part of the pandemic, but then that really set customer expectations and business expectations a lot around how they can be use technology to really digitally transform their businesses, and so as people started moving back into physical spaces, customers started moving back into physical spaces, it came with a fervor that I think has really accelerated some interesting opportunities in the signage space. Opportunities and threats too, as you mentioned, security and data protection and these things are becoming more and more of a concern. Updating, if you have more screens and more kiosks in your physical space, the kind of traditional operating systems that were being used, don't lend themselves well to that, right? They don't lend themselves well to being updated, being patched, being managed remotely. I think we've all seen blue screens in airports and different types of signs before. That's becoming more and more challenging, just the reliability and remote management.  So as these trends are starting to really put pressure on a lot of businesses, that's where Chrome OS is starting to really be considered more and more as a robust platform that can really help accelerate the next phase of digital transformation in these physical spaces. I get the argument for Windows and the bloatware and the crap on there and the updates you can't control and all those sorts of things. It's less of an issue with Linux but there's still an issue?  Naveen Viswanatha: Linux is an interesting platform. We don't see it too much ourselves but I think one of the challenges with Linux has to do with that it can do anything you really want it to, but in order to get it, to do what you want, it takes a lot of tuning, a lot of configuration, a lot of setup, and so I think you'll be spending the cost as an organization on either building up the technical capacity and knowing how to do that and really piecemealing a solution together, and at some point you're probably gonna ask yourself, is it worth it for our business to really become a Linux expert for our digital signage and kiosk strategy? Is that really core to driving the customer experience or should we rely on a platform like Chrome OS to give us a lot of that as part of its core capability?    And if you're using something like Chrome OS as a software firm, is there less demand to have in-house expertise around an operating system, if you're using something like Chrome versus Linux?  Naveen Viswanatha: Yeah, I would say that's one of the common benefits that we've seen. Recently I spoke to a retailer abroad in Asia, and they were saying that they saw an 80% reduction in staff having to focus on updates and management of the platform, and I asked the question because I wasn't sure if they said 80% or 18% because 80% sounded really startling and in fact they said no 80%, and now these individuals, they're effectively being focused on higher order capabilities with higher order needs within the organization rather than just going out and servicing screens and devices that needed to be updated, they're focusing more on higher value business objectives. And so absolutely, I think this is one of the areas where businesses need to ask themselves is this core, or is it context? It means core to obviously incorporate digital signage and service options within your business, but is it core for your organization to understand exactly how an operating system is gonna work? One of the arguments that a very successful company in the digital signage space called BrightSign makes … they are spin out of Roku and the CEO is saying that one of the reasons there's a lot of attraction to our hardware is we don't really have an operating system. It's our own proprietary operating system. So there's nothing to really hack. There's nothing you can do with it.  I understand the risk with Windows and to a lesser degree with Linux are, and I know you do harden Chrome, but what are there ways in? And if there are, please explain them to me. (Laughter) Naveen Viswanatha: That's actually one of the areas that I think we have a very strong track record around, and I will add that systems will get compromised over time, and unless you have a security team, a large robust security team, actively monitoring and ensuring that exploits and vulnerabilities are gonna be patched consistently, that turnaround time needs to be very quick, and that's exactly what we do on the Chrome OS side, and I think you can look at our track record. We have zero ransomware attacks ever reported on Chrome OS.  It's also another component that if you double click into the security piece of Chrome OS, it's really baked into the operating system. Many other operating systems out there will think about security as a bolt on afterthought. It's core to exactly how Chrome OS works. I'll give you a couple of examples.  Executables are blocked from running on the operating system, they're just blocked. And so that's a huge vector of vulnerability that is just removed entirely. Timely security updates, like I was talking about before. We have the ability to roll out updates on a four week cycle. Even if you're part of our long term stable channel so organizations that don't choose to get four week updates on the operating system, they wanna actually get six month updates instead, even if you're on that six month long term stable support channel, we will still roll out critical security updates to you. So you get the best of both worlds, right? And again, we have a whole team of people that are watching and monitoring what kind of vulnerabilities are out there on a consistent basis, and I'll mention one more thing really quickly and that is that the operating system files are kept in a complete, separate partition, so they can't be modified at all. So let's say with kiosk, your app is hacked in some way, or there's a vulnerability in the application that you're building, the operating system itself is hardened and entirely isolated from the application session itself. It's just a handful of things to think about.  I think any chief information security officer or CIO or organization that's really looking at security needs to evaluate it broadly, and we have a lot of great material that can tell you beyond what I've said here. Why Chrome OS is a very hardened and safe operation. I suspect you've also learned a lot through the years too. I know that some of the companies who were early on with Google using Chrome OS, they were frustrated by new versions that would break their software, and I think you got to a point pretty quickly where you started to pin the OS versions and a company could stay on that until they're ready to move to the next one instead of being auto-updated.  Naveen Viswanatha: Yeah, and we have learned a lot over the last several years, and you bring up a good point. One of the design principles that we really try to anchor on, when you think about what a business wants, they want predictability and control. They wanna know when things are gonna change, they wanna have the control to be able to initiate those changes.  Even if we have this release train rolling out great new updates, security updates, new features. As a business, you want to be able to throttle that, and yeah, we have a number of different controls that have allowed organizations to do that. A long term stable and support channel, which I mentioned expands the actual stable channel that the operating system is on for six months. So that was a big one that we announced earlier this year. But in addition to that, the ability to, like you said, pin different application versions and be able to know exactly when you wanna roll those out, there's a number of other controls that allow you to better understand how you're gonna update your fleet.  So tell me about Flex.  Naveen Viswanatha: Ah, we're super excited about Flex. So that was one of the three big announcements we had around CER. The first one was the Chrome enterprise recommended solution track that you alluded to earlier. The second one was a brand new SKU that's focused specifically on kiosks and digital signage, and we can get to that in a moment too, and the third one was the incorporation of Flex.  So Flex is something that we announced earlier this year and what it allows organizations to do is install Chrome OS on any device they already have. So if you have an existing investment, say in Windows devices, they're aging, you're not sure when you're gonna refresh them, maybe you wanna refresh part of them but you wanna get the benefits of Chrome OS, the security, the built in updates, everything we've been talking about thus far, remote management, you can now install Chrome OS Flex on those devices and get all of the benefits from Chrome OS. So we've seen that as a really interesting opportunity in the kiosk space as many customers are starting to use that as an. Chrome OS. So they'll maybe extend the life of their existing infrastructure for a couple of years, and then we'll see them roll onto Chrome devices in the future, but we've also seen organizations look at Chrome OS Flex as a way to really tailor what they want in terms of device capabilities for their signage solutions based on the breadth of different hardware and endpoints that exist out there today. So for example, if you wanted an existing device that is not a Chrome OS device, either based on the aesthetics of it, based on the form factor or performance, is it ruggedized, fanless, et cetera. You can look at that and say I wanna use that device. It's not a Chrome OS device, but with Flex now, I can transform that into a Chrome OS device and incorporate it into my overall device strategy. So why can you extend your life? Is that because it's a leaner application and strips out a lot of stuff? Naveen Viswanatha: It's because we're able to really look at the hardware and separate the hardware from the software, and so rather than relying on Microsoft's operating system support and when that's gonna be EOLd (end of lifed) or when the device itself be becomes EOLd, Chrome OS Flex allows us to effectively say, look, that's an end point and we're gonna separate the software and the operating system from the actual device components. As an organization there creates an abstraction layer for you to utilize Flex as a way to extend the life of that infrastructure.  I assume you could also run a blended network as well, so that you could have Chrome OS devices and re refurbed windows or reclaimed windows devices as Flex devices and run concurrently. You don't have to have a network, that's just all pure Chrome OS devices.  Naveen Viswanatha: Yeah, you hit the nail on the head and that's what we're starting to see with many of our customers who will start with Chrome OS flex, but then they'll say … a lot of organizations, especially larger organizations, they don't necessarily have one device on one operating system or one endpoint or one operating system, they have a plethora of them and these devices might be on different refresh and end of life cycle.  So when there might be one coming up, say, at the end of next year, Chrome OS Flex is a great way to evaluate Chrome OS capabilities. Most of the time customers overwhelmingly are happy with Chrome OS and start using that as an onboarding mechanism for other Chrome devices or then rolling out Flex to other parts of their fleet that might be the end of lifting and subsequent years. And so during that time, they will have, like you said, a hybrid model of Chrome OS devices, as well as Flex devices, and you can absolutely manage those through the single pane of glass, like via the partner pane of glass, one of the nine partners that we just announced, or even our own admin console. You mentioned a new SKU. What is that?  Naveen Viswanatha: Yeah we're very excited about that. The new SKU is called the kiosk and signage upgrade, and what it does is it unlocks all of the signage capabilities that an organization wants, but none of anything else that you need. And what I mean by that is that Chrome OS is an operating system that serves end user computing, as well as signage. On the end user computing side, you need capabilities to manage users, user profiles, logins, different types of login modalities. But on the signage side, you don't really need that, right? Even if there's end user interaction, there's a lot of user modes and user capabilities that are not part of that overall management… Because it's a dumb end point in a hell of a lot of cases?  Naveen Viswanatha: I wouldn't use the word dumb, but because it's a highly focused endpoint, and as a result of that, we tailored a SKU which is $25 per device per year. So that's half off, two bucks a month basically, enterprise SKU, and for that, you get this 50% off SKU and very focused functionality, still gives you all the security, all the device controls, cloud management, reporting and insights. You just don't get the user controls that you get with the Chrome enterprise upgrade SKU, and that's the full SKU.  But if you did want those user controls, for whatever reason it may be, could you use those? And could you run a blended network with both kinds of licenses?  Naveen Viswanatha: Absolutely and we have a lot of customers that that, that are doing exactly  One thing that came up a few years ago and there was some buzz around it, but I don't know where it went. There was chatter that Android, which is pretty widely used in digital signage as well, was going to converge with Chrome OS and it was going to be the same thing that didn't really happen or did I miss it?  Naveen Viswanatha: No, it didn't happen. I've been on the team for seven years, so I'm not sure if what you're referring to is before my time, but we do have Android and Chrome OS as a company, two operating systems that serve different parts of the overall market. Now you're right that there is going to be some overlap. We see Android in the signage space. We see Android focusing a little bit more on mobile kiosk type of use cases. So a customer associate in a store walking around with a tablet style device, so things along those lines, whereas Chrome OS feels like it's a bit more focused on fixed facility types of infrastructure, and that's how we see the segmentation today. And we obviously worked very closely with the Android team.  Over time I think, as things evolve somewhat organically, if there are opportunities to bring these two capabilities or two operating systems together, that's something that we will consider but today we see a pretty natural segmentation. One thing I will add is that you were talking about managing a blended environment. With the Chrome OS capabilities and Android management capabilities, many organizations are managing both Chrome OS and Android endpoints through their universal endpoint management solutions. So that is a way that these two solutions can coexist even today.  This has been great. I could have talked for at least an hour or more, but we committed to a certain time window, so I should honor it. The last question I wanted to ask is just very simply if software companies and solution providers wanna get involved, or at least look into this how do they start? Naveen Viswanatha: Yeah, so you can go to our website. We have a lot of great information on our website. For customers, we have a wayfinding guide. We have information about the different solutions that we have for kiosk in terms of both devices that they can use at as endpoints, as well as peripherals that they can also utilize.  On the partner side, on the solution provider side gets in contact with our business development team. I know we are actively looking at working with more and more partners. I mentioned earlier that we listed nine and that's just a starting point, and what we've seen is that on the solution provider and ISV side, as you scale out globally, there are a lot of kinds of localized partners that do a lot of work in different regions, and so we expect this area to really build out significantly over the coming years. So get in touch with our BD team and our business development team, and be happy to work with you, figure out ways to incorporate you into our Chrome enterprise recommended program. As you dug into this, were you surprised by how many CMS software companies are out there?   Naveen Viswanatha: Yeah, I absolutely was. Especially considering where we were just five years ago or so. It seems like this has been one of the areas where we've seen a lot of hyper specialization and hyper localization. So unlike other solution categories like contact center, as an example, you tend to have a number of global players and then a few localized players within each market.  In this particular arena, in kiosks and digital signage, it feels very different because you look at APAC. I can't even talk about APAC as a market because each country, and sometimes even within countries, different specializations with retail versus employee spaces and workspaces has created a huge ecosystem around kiosks and signage. So yes, long answer in terms of in terms of your original question, but absolutely.  That's good for me because a crowded market means there's more to write about and talk about. (Laughter) Well, thank you very much for spending some time with me! Naveen Viswanatha: Thank you, and appreciate the time and opportunity, and I look forward to talking to you again at some point. 

The Current Procedural Terminology ® (CPT) definition of Modifier 25 is that it is used to report an evaluation and management (E&M) service on a day when another service was provided to the patient by the same physician or other qualified healthcare professional. Think of Modifier 25 as a “protective” modifier when minor procedures or services are performed on the same date as an E&M office visit. If both services are medically necessary, both are paid, if the Modifier 25 has been appended to the E&M.  Recently, though, several payers, including Horizon Blue Cross in New Jersey, Horizon Medicare Advantage Plans, and Cigna Healthcare, to name a few, are now scheduled to cut provider payments when a Modifier 25 is used, creating burdensome paperwork to delay claims.Since this late-breaking news is a developing story, we have asked nationally recognized professional coder, auditor, and consultant Terry Fletcher to report on its impact on physicians during the next live edition of Talk Ten Tuesdays.The live broadcast will also feature these other segments:Coding Report: Laurie Johnson, senior healthcare consultant with Revenue Cycle Solutions, LLC, will report on the latest coding news.Talk Law: Brianna J. Santolli, Esq., a healthcare and litigation attorney with Riker Danzig LLP, will continue with the broadcast's newest segment. News Desk: Timothy Powell, CPA, a consultant with Besler, will anchor the Talk Ten Tuesdays News Desk.Journaling John: John Zelem, MD, FACS, founder and CEO for Streamline Solutions Consulting, will continue with his second journal entry in this new segment.Point of View: Susan Gatehouse, a guest cohost who will be substituting for Dr. Erica Remer, will report on a current healthcare topic that has caught her attention.

Episode Summary: RVU's (Relative Value Units) are the currency of healthcare. Hosts and General Surgery Certified Coders Neal Sheth and Dr. Piyush Sheth explore the concept of RVU's and Geographic Practice Cost Indices and how CMS makes payments. Visit our blog: unravelingmedicalcoding.com Don't forget to subscribe to our podcast: Unraveling Medical Coding Coding Solutions: General Surgery, 2022 is available now on Amazon

In early May, CMS released the inpatient prospective payment system proposed rule for fiscal year 2023. In this year's proposal CMS introduced several policies aimed at addressing health equity. Among those is a data collection condition that would require a provider to attest that their organization is capturing SDOH measures. Eric Fontana, Vice President of Client Solutions at Optum Life Sciences, has spent much of his career helping health care leaders make sense of data and regulations. In this special Open Mic edition of Radio Advisory, Eric shares his thoughts about why this could be a game-changer for researchers. Interested in sharing your thoughts about health care on an Open Mic? Pitch us your idea by emailing podcasts@advisory.com. Links: The 2023 inpatient proposed rule: What you need to know IPPS Regulations and Notices [CMS website]

This week I review another forum plugin: Discussion Board [powerpress]

In this episode of Syntax, Wes and Scott talk about the new viewport units coming to the web - what are they and when can we use them? LogRocket - Sponsor LogRocket lets you replay what users do on your site, helping you reproduce bugs and fix issues faster. It's an exception tracker, a session re-player and a performance monitor. Get 14 days free at logrocket.com/syntax. Sanity.io - Sponsor Sanity.io is a real-time headless CMS with a fully customizable Content Studio built in React. Get a Sanity powered site up and running in minutes at sanity.io/create. Get an awesome supercharged free developer plan on sanity.io/syntax. Show Notes 00:25 Welcome 01:14 Sponsor: LogRocket 02:24 Sponsor: Sanity 04:19 What are viewport units? The Large and small and dynamic viewports 05:22 What are the new viewport units? Large small and dyanmic viewports 07:57 What's small and large? 11:52 How do viewport units help developers? 12:39 What about the keyboard on mobile? Keycode.info 16:37 When can we start using new viewport units? Tweet us your tasty treats Scott's Instagram LevelUpTutorials Instagram Wes' Instagram Wes' Twitter Wes' Facebook Scott's Twitter Make sure to include @SyntaxFM in your tweets

Charlotte City Council goes on a spending spree, approving funds for arena renovation, a Hornets practice facility and a study for the final leg of the streetcar. Plus, CMS gets ready to auction 46,000 clear backpacks. Those stories and more.

Last week, the Federal Trade Commission launched a formal inquiry into pharmacy benefit managers (PBMs).Listen to Health Affairs' Leslie Erdelack and Vabren Watts discuss the FTC's probe into PBMs and how vertical integration and consolidation may affect patients and health care consumers.Related Links: FTC Launches Investigation Into Major Pharmacy Benefit Managers' Business Practices (FierceHealthcare) A Six-Step Solution To The PBM Problem (Health Affairs Forefront) On Drug Prices, Pharmacy Benefit Managers Are Not The Problem (Health Affairs Forefront) PBM Oversight, Insulin Cost-Sharing Provisions Among Build Back Better Act (Health Affairs Forefront)  Currently, more than 70 percent of our content is freely available — and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

Tune into the first episode in the Avalere Health Essential Voice podcast series focused on how CMS and Medicare coverage decisions define patient access. In this segment, our Market Access experts discuss national coverage determinations (NCDs), specifically those with coverage with evidence development (CED), their impacts to patient access, and considerations for life sciences companies.

Six months left. That's how long practices have to adjust to the new CMS billing guidelines that include rules around split/shared visits between physicians and advanced practice providers (APPs). Once it happens, it will be a huge disruption to how split/shared patient care is delivered and reported. On this episode of Modern Practice, we discuss the impact of these new guidelines and how practices can get prepared and respond effectively.   Guest speakers: Christen Hunt, DNP, NP-C, CPNP-AC Senior Director Clinical Team Insights Vizient   Jennifer Sarno, MSN, ACNP-BC, CPHQ Programmatic Advisor Director Clinical Team Insights Vizient   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Principal Clinical Operations and Quality Vizient   Show Notes: [01:29] New rule [02:53] A huge disruptor for team-based practice [04:16] The rationale behind the new guidelines [05:00] Impact of the new guidelines [06:36] Forcing the evolution to true reporting and metrics [07:25] Tracking time   Links | Resources: To contact Modern Practice: modernpracticepodcast@vizientinc.com Christen Hunt's contact email: christen.hunt@vizientinc.com Jennifer Sarno's contact email: jennifer.sarno@vizientinc.com Calendar Year (CY) 2022 Medicare Physician Fee Schedule Final Rule (CMS) – includes information on 2023 split/shared visits Click Here   Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify Stitcher RSS Feed  

We wanted to get to know our neighbors, so we threw a block party - you can do the same! How do we effectively communicate with people and how did the ancients do it? http://www.patreon.com/thecatholicmanshow (Become a Patron! Over 40 interviews, a course with Karlo Broussard, a 10 part series on the domestic church, a course on fitness and virtue by Pat Flynn, and free thank you gifts for supporting the show!) https://selectinternationaltours.com/catholicmanshow/ () WE ARE GOING TO IRELAND WITH FR. SEAN DONOVAN AND THERE ARE STILL A FEW SPOTS LEFT! JOIN US – https://selectinternationaltours.com/catholicmanshow/ (MORE DETAILS HERE). About our drink: https://www.oldelk.com/lineup (Old Elk Whiskey) The key to our bourbon is our high malted barley content in our mashbill. By investing in our bourbon and using four times more malted barley than traditional recipes, we've created a non-traditional bourbon that generates sweet and light components. The malted barley combined with the spicy essence of clove from the rye, and the classic rich bourbon character from the corn, amounts to a robust and smooth taste profile. About our gear: Throw a neighborhood block party! How do you do it? Why should you do it? Let's discuss. About the Topic: How do we effectively communicate to others? Sharing the gospel is important but we need to do it in a way in which it can be received well. How do you write a tough email? Or plan a business pitch? How did some of the best of old do it? Let's discuss. This episode is sponsored by: https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS (CHRIST CENTERED CAPITAL) We point out what companies, organizations and charities are aligned with Christian Values, and which are not, so you can make morally informed decisions on what to do with your capital. https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS (Use promo code TCMS2022 for a 1 month free subscription. ) https://christcenteredcapital.com/?utm_source=CMS&utm_medium=CMS&utm_campaign=CMS () http://exodus90.com/tcms (What's your holy hour look like? ) There's a common thread among thousands of formerly sinful people we now call Saints. They had a relationship with God. Which then inspired them to ‘set the world on fire' as Catherine of Sienna put it. But, more specifically, it meant they put in the time. They sat with the Lord. Spoke with Him. Listened to Him. Daily. They unveiled their hearts and wounds and problems to Him. They offered him thanks and gratitude. They left their sufferings with Him on the altar. They begged for His help. My question to you: are you putting in the time? I'm not talking about time to just talk at Him or sit in church making a mental grocery list. I'm talking about time to build a consistent, honest relationship. Time to speak, and time to listen. Whether you want to pray a daily holy hour or hit up adoration once a week, I have a guide here from the makers of Exodus 90 specifically about praying a Holy Hour. Inside, you'll find a simple breakdown that shows you how to structure your time with the Lord. You can grab the mobile-friendly guide for free at http://exodus90.com/tcms (Exodus90.com/tcms) TIME CODES: If this is your first time listening to The Catholic Man Show, we do 3 things almost every episode:1.) Open, review, and enjoy a man beverage – Minutes 1-12.2.) Highlight a man gear – Minutes 12-24.3.) Have a manly conversation – Minutes 24-48If you haven't listened to The Catholic Man Show before, check out our previous episodes https://thecatholicmanshow.com/episodes/ (here). Subscribe to our https://www.youtube.com/channel/UC5MhmMZZhEnrapVYUIkFHLg?view_as=subscriber ( YouTube channel) to watch past episodes. Want to help The Catholic Man Show?...

This episode is hosted by Dr. Gregory Worsowicz, a Physiatrist and Senior Associate Consultant at Mayo Clinic in Florida. He discusses CMS-13 and advocacy with Dr. John Melvin, a Clinical Professor with the Department of Physical Medicine and Rehabilitation at Thomas Jefferson University.

In this episode of Syntax, Wes and Scott answer your questions about headless WordPress, Regex, their health and fitness, CSS custom properties in media queries, and more. Sentry - Sponsor If you want to know what's happening with your code, track errors and monitor performance with Sentry. Sentry's Application Monitoring platform helps developers see performance issues, fix errors faster, and optimize their code health. Cut your time on error resolution from hours to minutes. It works with any language and integrates with dozens of other services. Syntax listeners new to Sentry can get two months for free by visiting Sentry.io and using the coupon code TASTYTREAT during sign up. Sanity - Sponsor Sanity.io is a real-time headless CMS with a fully customizable Content Studio built in React. Get a Sanity powered site up and running in minutes at sanity.io/create. Get an awesome supercharged free developer plan on sanity.io/syntax. .TECH Domains - Sponsor .TECH is taking the tech industry by storm. A domain that shows the world what you are all about! If you're looking for a domain name for your startup, portfolio, or your own project like we did with uses.tech, check out .tech Domains. Syntax listeners can snap their .TECH Domains at 80% off on five-year registration by visiting go.tech/syntaxistech and using the coupon code “syntax5”. Show Notes 00:10 Welcome 03:30 If I host a NextJS app on Digital Ocean, should I use a Digital Ocean database? 09:14 Will either of you ever do a regex course? Regex101 13:58 Is it possible to use the WordPress users database as the same database that the app uses? WPGraphQL 18:46 Sponsor: Sentry 19:43 How is health and fitness going for the both of you? 26:08 Does Wes know who Gendo Ikari is? 27:36 Dart popularity follow up 29:40 Is it vital that I should learn another programming language? 33:42 Sponsor: Sanity 34:54 If I'm trying to get my first job in web development, do I need to be familiar with design software? Figma 40:01 Thank you for the confidence to apply for a web dev job Syntax 463 with Tom Preston-Werner 41:55 What advice will you give in terms of setting up core important things around network, state management, folder structure? 45:37 .TECH Domain Names 46:22 I just had an interview with a “major tech company” and your article on using string templates was really helpful. Template Strings 48:43 If 80% of the time ew need to use preventDefault on form submission, why don't the simply change the HTML spec? 50:01 What's the rationale for not supporting CSS custom properties in media queries when using max/min width? CSS Env MDN CSS Env 55:37 ××× SIIIIICK ××× PIIIICKS ××× ××× SIIIIICK ××× PIIIICKS ××× Scott: * You Must Remember This Podcast Wes: Tools Shameless Plugs Scott: LevelUp Tutorials Wes: Wes Bos Tutorials Tweet us your tasty treats Scott's Instagram LevelUpTutorials Instagram Wes' Instagram Wes' Twitter Wes' Facebook Scott's Twitter Make sure to include @SyntaxFM in your tweets

Publishing is way behind other industries when it comes to technology consolidation. Compared with five or six key software platforms in most sectors, it is not uncommon to see publishers running their businesses on 50 or 60 separate set ups. There are clear advantages in leaving this ‘Tech Soup' behind and migrating to a unified technology platform. For this special Conversations episode, we're joined by Markus Karlsson, CEO of Affino, the Unified Business Platform for media, publishing and membership organisations, and Steve Hinds, Digital Editor and Product Manager at leading travel news industry site TTG Media. We discuss the benefits of systems consolidation, from improved operational efficiency to increased profitability, as well as exploring some of the challenges publishers face when looking to consolidate, and how they can get the process started. This Conversations episode is sponsored by Affino. Founded 2009, Affino is the leading Unified Business Platform for media, publishing, events, membership and professional services organisations. The Affino SaaS Platform provides a complete solution for engaging with and monetising audiences. It combines full-range Audience CRM with Sales and Marketing Automation, Ecommerce, Subscriptions and Memberships, Messaging, CMS, Events, Ad Serving, and Recruitment. Affino streamlines organisations for more efficiency, cost-effectiveness, and productivity, as well as delivering numerous new and unique revenue stream capabilities. The fully GDPR-compliant system is built on the principles of Actionable Intelligence – prompting and triggering intuitive rapid responses based on fully accurate and comprehensive first-hand real-time data. Learn more about Affino on their website, or contact Markus on engage@affino.com.

Has the U.S. Department of Health and Human Services (HHS) clarified which telehealth services are valid for data submissions for the HHS-operated risk adjustment (RA) program? Moreover, can Hierarchical Condition Category (HCC) ICD-10-codes – the risk-adjustment model designed to estimate future healthcare costs for patients – be used when the services reported are provided under the public health emergency (PHE) telehealth waivers? You need to know. And you will, when you listen to the next live edition of Talk-Ten-Tuesdays, coming your way Tuesday, June 14 at 10 a.m. EST. That's when nationally recognized professional coder, auditor, consultant, and author Terry Fletcher will report on the regulatory guidance from the Centers for Medicare & Medicaid Services (CMS) to help ensure you remain compliant.The live broadcast will also feature these other segments:Coding Report: Laurie Johnson, senior healthcare consultant with Revenue Cycle Solutions, LLC, will report on the latest coding news.News Desk: Timothy Powell, CPA, and a consultant with Besler, will anchor the Talk-Ten-Tuesdays News Desk.Journaling John: John Zelem, MD, FACS, founder and CEO for Streamline Solutions Consulting, will continue with his second journal entry in this new segment.TalkBack: Erica Remer, MD, founder and president of Erica Remer, MD, Inc. and Talk-Ten-Tuesdays co-host, will report on a subject that has caught her attention during her popular segment.